Can this test help guide the selection and composition of allergen immunotherapy (AIT)?

Yes. By distinguishing true primary sensitizations from cross-reactive sensitizations, ALEX®3 can support clinical decision-making when considering allergen immunotherapy (AIT).
The detailed sensitization profile provided by ALEX®3 helps identify the most relevant allergens to include in a personalized immunotherapy strategy.